secwatch.observer — SEC 8-K summary
======================================

Issuer:     DocGo Inc. (DCGO)
CIK:        0001822359
Form:       8-K
Filed at:   2023-03-13T23:59:59+00:00
Accession:  0001213900-23-019594
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DocGo FY2022 revenue $440.5M (+38% YoY); guides 2023 revenue $500-$510M, Adj. EBITDA $45-50M
--------------------------------------------------------------------------------

- Full-year 2022 revenue $440.5M, up 38% YoY; net income $30.7M (+60%); Adjusted EBITDA $41.3M (+65%).
- Q4 revenue $108.8M vs $121.3M (Q4 2021 had $50M COVID revenue); transport revenue up 98% to $37M.
- 2023 guidance: revenue $500-510M (14-16% as-reported, 36-40% ex-COVID); Adj. EBITDA $45-50M; gross margin ~35%.
- Backlog of $180M over three years; 34 active RFPs totaling over $1B; $90M Citibank credit line unused.
- Since Jan 2023, awarded over $180M in new business across US and UK, including health system contracts; hiring hundreds, adding 100+ vehicles.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822359/000121390023019594/0001213900-23-019594-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822359/000121390023019594/ea175098-8k_docgoinc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-019594

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer